BiotechTube
ARKRAY

ARKRAY

Minneapolis, United States· Est.
arkrayusa.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

ARKRAY USA, a subsidiary of the larger Japanese ARKRAY group, is a well-established player in the global diabetes diagnostics market, headquartered in Minneapolis, USA. The company's core business revolves around manufacturing and distributing a wide range of blood glucose meters (under the GLUCOCARD brand), test strips, and lancing devices (under the TechLITE and Assure brands). With a history dating back to 1960, it has evolved into a revenue-generating commercial entity with a significant international footprint across North America, Europe, Asia Pacific, and other regions. Its strategy focuses on continuous product innovation and maintaining a strong presence in the competitive point-of-care and self-monitoring blood glucose markets.

Diabetes

Technology Platform

Electrochemical biosensor platform for blood glucose measurement, encompassing blood glucose meters, test strips, and lancing devices.

Opportunities

Growth in emerging markets with rising diabetes prevalence and expanding healthcare access presents a significant opportunity.
The company can also leverage its core biosensor expertise to expand into adjacent point-of-care diagnostic tests.
Maintaining a strong position in the cost-sensitive value segment of the glucose monitoring market remains a key opportunity.

Risk Factors

The core SMBG business faces disruption from advancing Continuous Glucose Monitoring (CGM) technologies.
Intense competition from larger, well-resourced players and sustained pricing pressure from global healthcare payers threaten market share and profitability.

Competitive Landscape

ARKRAY competes in a highly consolidated global market dominated by giants like Roche (Accu-Chek), Abbott (FreeStyle), LifeScan (OneTouch), and Ascensia Diabetes Care. The competitive landscape is defined by fierce competition on price, brand loyalty, distribution reach, and product features, with an overarching trend of market evolution towards integrated CGM systems.

More companies in Diagnostics & Precision Medicine →More companies in United States →